Activating Compound | Comment | Organism | Structure |
---|---|---|---|
dithiothreitol | at least 10 mM required for full activity | Leishmania major | |
tris(2-carboxyethyl)phosphine | at least 0.5 mM required for full activity | Leishmania major |
Application | Comment | Organism |
---|---|---|
medicine | overexpression of active PPI in Leishmania major impairs differentiation from the procyclic promastigote to the infective metacyclic promastigote. PPI does not protect against the natural antimicrobial peptide gomesin | Leishmania major |
Cloned (Comment) | Organism |
---|---|
N-terminal His-tagged native or mutant PPI expressed in Escherichia coli BL21(DE3) | Leishmania major |
Protein Variants | Comment | Organism |
---|---|---|
C210A | no detectable activity | Leishmania major |
E101Q | ca. 2% activity of the native enzyme | Leishmania major |
E107Q | ca. 50% activity of the native enzyme | Leishmania major |
H234S | no detectable activity | Leishmania major |
additional information | PPI-deficient mutants show no detectable phenotype, retain infectivity to macrophages in vitro and in mice | Leishmania major |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-Pyrrolidinone | 1 mM inhibits by 44% | Leishmania major | |
Cu2+ | 1 mM inhibits by 91.3% | Leishmania major | |
iodoacetamide | 0.1 mM strongly inhibits by 98.3% | Leishmania major | |
iodoacetic acid | 0.1 mM completely inhibits | Leishmania major | |
additional information | Ca2+, Mg2+, Na+, Li+, pepstatin A, 1,10-phenanthroline, benzamidine, bestatin and trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane have no or little inhibitory effect | Leishmania major | |
N-ethylmaleimide | 0.1 mM strongly inhibits by 98.1% | Leishmania major | |
Ni2+ | 1 mM inhibits by 99%, 0.1 mM inhibits by 48% | Leishmania major | |
phenylmethylsulfonyl fluoride | 1 mM inhibits by 53.4% | Leishmania major | |
Zn2+ | 1 mM inhibits by 80.2% | Leishmania major |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0335 | - |
L-pyroglutamyl p-nitroanilide | - |
Leishmania major |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Leishmania major | 5829 | - |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
30270 | - |
sequence analysis | Leishmania major |
36000 | - |
gel filtration | Leishmania major |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Leishmania major | - |
- |
- |
Purification (Comment) | Organism |
---|---|
by Ni-affinity chromatography and gel filtration | Leishmania major |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
promastigote | - |
Leishmania major | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-pyroglutamyl-beta-naphthylamide + H2O | - |
Leishmania major | L-pyroglutamate + 2-naphtylamine | - |
? | |
L-pyroglutamyl-p-nitroanilide + H2O | - |
Leishmania major | L-pyroglutamate + p-nitroaniline | - |
? |
Synonyms | Comment | Organism |
---|---|---|
PPI | - |
Leishmania major |
pyroglutamyl aminopeptidase I | - |
Leishmania major |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
additional information | - |
optimal activity between 8.8-10.5, activity decreases rapidly below pH 8.0 | Leishmania major |